Managing for a Wired Health Care Industry
Convergence-the increasing overlap of media, computing, and communications-is providing broad connectivity for a wealth of digitized health care information that is being developed by health care providers, technology companies, and consumers themselves. This article examines the impact of convergence on the health care industry and identifies the strategic questions it raises for pharmaceutical and device manufacturers.
You may also be interested in...
The RNA drug’s accelerated approval brings Sarepta’s exon-skipping market share to nearly 30%.
Limiting interactions to two-dimensional settings will hinder collaboration, innovation and the mentoring of younger employees, Merck & Co. CEO Kenneth Frazier says. Frazier, who will retire in June, is looking forward to returning to public service but says "politics with a capital P is not my thing."
BioMedican is ready to produce CBG, cannabigerol, and THC-V, tetrahydrocannabivarin, through biosynthesis and plans by the end of the year to start making CBN, cannabinol, and THC-A, tetrahydrocannabinolic-acid.